Prostate Cancer Imaging Market Size
Prostate Cancer Imaging Market size was valued at USD 913.7 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 5.70% over the forecast period 2024-2031.
The rising prevalence of prostate cancer is driving the demand for imaging devices. For instance, according to the National Cancer Institute, in the U.S., around 174,650 new cases were diagnosed in 2019. Also, increasing technological advancements in imaging devices are expected to further fuel market growth over the forecast period. According to the research report, the global market is divided into five major regions such as North America, Europe, Latin America, Asia Pacific, the Middle East and Africa, and the Rest of the world. Among all regions, the North American region has the highest share in the global market share, and it is continuing its dominance over the forecast period 2024-2031. The Asia Pacific region is expected to produce the fastest growth rate over the forecast period 2024-2031.
Market Summary
| Metrics | Details |
| Market CAGR | 5.70% |
| Segments Covered | By Type, By Solution, By End User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Prostate Cancer Imaging Market Dynamics
Increasing Prevalence of Prostate Cancer.
The increasing prevalence of prostate cancer is one of the important factors, which is expected to boost the growth of the market throughout the forecast. Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth leading cause of death worldwide. Prostate cancer may be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. based on GLOBOCAN 2018 estimates, 1,276,106 new cases of prostate cancer were reported worldwide in 2018, with a higher prevalence in developed countries.
Increasing Old Aged Male Population
The increasing old-aged male population is one of the main factors, which can be responsible for boosting the growth of the global prostate cancer imaging market. The global population aged 60 years or over numbered 962 million in 2017, more than twice as large as in 1980 when there were 382 million older persons worldwide. The male geriatric population is prone to prostate cancer, hence, the increasing old-aged male population is responsible for the significant growth of the global prostate cancer market.
